Zhipeng Wang
Qinghai University(CN)University of Electronic Science and Technology of China(CN)Stockholm University(SE)Second Military Medical University(CN)Dalian Institute of Chemical Physics(CN)Anhui Medical University(CN)Chinese Academy of Sciences(CN)China University of Petroleum, Beijing(CN)Beijing Normal University(CN)Sichuan Agricultural University(CN)Shanghai Changzheng Hospital(CN)Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital(CN)Advanced Energy Materials (United States)(US)First Affiliated Hospital of Anhui Medical University(CN)Changzhou No.2 People's Hospital(CN)Changzhou Third People's Hospital(CN)Bolin Centre for Climate Research(SE)Yunnan University of Traditional Chinese Medicine(CN)Northwest A&F University(CN)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Cancer Treatment and Pharmacology, Pharmacological Effects of Natural Compounds
Most-Cited Works
- → Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression(2009)131 cited
- → Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells(2016)88 cited
- → Triptolide inhibits ovarian cancer cell invasion by repression of matrix metalloproteinase 7 and 19 and upregulation of E-cadherin(2012)79 cited
- → Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients(2017)77 cited
- → Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer(2015)77 cited
- → Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer(2016)